Vitamin D, Cognition, and Dementia: a Systematic Review and Meta-analysis
Authors
Affiliations
Objective: To examine the association between cognitive function and dementia with vitamin D concentration in adults.
Methods: Five databases were searched for English-language studies up to August 2010, and included all study designs with a comparative group. Cognitive function or impairment was defined by tests of global or domain-specific cognitive performance and dementia was diagnosed according to recognized criteria. A vitamin D measurement was required. Two authors independently extracted data and assessed study quality using predefined criteria. The Q statistic and I² methods were used to test for heterogeneity. We conducted meta-analyses using random effects models for the weighted mean difference (WMD) and Hedge's g.
Results: Thirty-seven studies were included; 8 contained data allowing mean Mini-Mental State Examination (MMSE) scores to be compared between participants with vitamin D <50 nmol/L to those with values ≥50 nmol/L. There was significant heterogeneity among the studies that compared the WMD for MMSE but an overall positive effect for the higher vitamin D group (1.2, 95% confidence interval [CI] 0.5 to 1.9; I² = 0.65; p = 0.002). The small positive effect persisted despite several sensitivity analyses. Six studies presented data comparing Alzheimer disease (AD) to controls but 2 utilized a method withdrawn from commercial use. For the remaining 4 studies the AD group had a lower vitamin D concentration compared to the control group (WMD = -6.2 nmol/L, 95% CI -10.6 to -1.8) with no heterogeneity (I² < 0.01; p = 0.53).
Conclusion: These results suggest that lower vitamin D concentrations are associated with poorer cognitive function and a higher risk of AD. Further studies are required to determine the significance and potential public health benefit of this association.
CPT1A ameliorates microglia-induced neuroinflammation via facilitating VDR succinylation.
Li W, Li Y, Chen Y, Wang Y, Qian L Sci Rep. 2025; 15(1):5181.
PMID: 39939672 PMC: 11822210. DOI: 10.1038/s41598-025-88298-5.
You W Health Sci Rep. 2025; 8(1):e70302.
PMID: 39777281 PMC: 11705424. DOI: 10.1002/hsr2.70302.
Ritter P, Glenn T, Achtyes E, Alda M, Agaoglu E, Altinbas K Int J Bipolar Disord. 2024; 12(1):43.
PMID: 39714599 PMC: 11666876. DOI: 10.1186/s40345-024-00364-5.
Liu J, Roccati E, Chen Y, Zhu Z, Wang W, He M J Alzheimers Dis Rep. 2024; 8(1):411-422.
PMID: 38549631 PMC: 10977452. DOI: 10.3233/ADR-230077.
Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
Kang J, Park M, Kim T J Alzheimers Dis. 2024; 97(4):1939-1950.
PMID: 38339931 PMC: 10894571. DOI: 10.3233/JAD-231033.